NDA 010721 · Casper Pharma LLC
Antivert
Meclizine Hydrochloride · Oral
Last checked: Nov 20, 2026Latest source record: Jun 28, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1957
Feb 14, 1957
Approved uses
n/a
Original approval plus efficacy supplements
Registered trials
11
1 Phase 3, 1 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
No approvals could be loaded from Drugs@FDA just now.
Clinical trials
Interventional ClinicalTrials.gov studies with "Meclizine" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
- Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral OriginPivotal-lookingCompleted
Apsen Farmaceutica S.A.Industry
NCT02112578 · 292 participants · Start Nov 1, 2016 · Primary completion Apr 1, 2017
Drug: Meclizine; Dimenhydrinate · For: Vertigo, Peripheral
Sites: Maringá, Brazil; Barueri, Brazil; Santo André, Brazil · 7 sites in all
- Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy VolunteersPivotal-lookingRecruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb companyBristol Myers Squibb (BMY)
NCT07681076 · 180 participants (planned) · Start Sep 3, 2026 · Primary completion Nov 30, 2026
Drug: KarXT; Trimethobenzamide and 2 more · For: Healthy Volunteers
Sites: Los Alamitos, California; Hollywood, Florida; Atlanta, Georgia · 4 sites in all
- Meclizine as a Potential Smoking Cessation TreatmentPivotal-lookingCompleted
Duke UniversityAcademic, hospital or other
NCT01443858 · 146 participants · Start Aug 2011 · Primary completion Dec 2012
Drug: Meclizine; Nicotine Patch and 1 more · For: Smoking Cessation
Sites: Charlotte, North Carolina; Durham, North Carolina; Raleigh, North Carolina · 4 sites in all
- The Effects of Antihistamines on Pre-Pulse InhibitionPivotal-lookingCompleted
Duke UniversityAcademic, hospital or other
NCT01537471 · 117 participants · Start Jan 2012 · Primary completion Sep 2012
Drug: Placebo; Meclizine and 1 more · For: Healthy
Sites: Durham, North Carolina
Repurposed Therapeutics, Inc.Industry
NCT05852730 · 80 participants (planned) · Start Aug 10, 2021 · Primary completion Sep 2026
Drug: DPI-386 Nasal Gel; Other (e.g., promethazine, meclizine) · For: Motion Sickness, Space; Motion Simulation; Parabolic Flight
Sites: Houston, Texas
Medical Corps, Israel Defense ForceAcademic, hospital or other
NCT03270839 · 54 participants · Start Jun 1, 2017 · Primary completion Sep 30, 2019
Drug: Bonine 25Mg Chewable Tablet; Kwells and 1 more · For: Drug Reaction
Sites: Haifa, Israel
- Meclizine Plasma Levels in Responders and Non-respondersStatus unknown
Medical Corps, Israel Defense ForceAcademic, hospital or other
NCT04482985 · 50 participants (planned) · Start Sep 1, 2020 · Primary completion Sep 1, 2021
Drug: Meclizine Hydrochloride · For: Seasickness; Meclizine
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Weibel S, Rücker G, Eberhart LH, et al. · Cochrane Database Syst Rev 2020 · Research Support, Non-U.S. Gov't, Systematic Review
- The effects of meclizine on motion sickness revisited.
Wibble T, Engström J, Verrecchia L, et al. · Br J Clin Pharmacol 2020 · Randomized Controlled Trial
- Airsickness prevention in helicopter passengers.
Estrada A, LeDuc PA, Curry IP, et al. · Aviat Space Environ Med 2007 · Randomized Controlled Trial
- Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia.
Matsushita M, Kitoh H, Mishima K, et al. · PLoS One 2023 · Clinical Trial, Phase I, Research Support, Non-U.S. Gov't
- An evaluation of the teratogenicity of certain antinauseant drugs.
Milkovich L, van den Berg BJ · Am J Obstet Gynecol 1976 · Clinical Trial, Comparative Study
- Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G, Soylu M, Demirel D, et al. · Arch Biochem Biophys 2022 · Meta-Analysis, Research Support, Non-U.S. Gov't
Sponsor: Casper Pharma LLC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.